Cancer antigen (CA) 19-9 is a protein on the surface of certain cells. CA 19-9 does not cause cancer; but it is produced by the tumour cells, making it useful as a tumour marker to follow the course of the cancer. CA 19-9 is elevated in most patients with advanced pancreatic cancer, but it may also be raised in other cancers and diseases such as bowel cancer, lung cancer and gall bladder cancer, as well as in benign diseases such as gall stones, pancreatitis, cystic fibrosis, and liver disease. Therefore elevated levels of CA 19-9 do not necessary mean the presence of pancreatic cancer. Very small amounts of CA19-9 may also be found in healthy patients.
Pancreatic cancer tumour marker
£147.20
CA 199 is a test to help tell the difference between cancer of the pancreas and bile ducts and other conditions; and to monitor response to pancreatic cancer treatment and to watch for recurrence. There are pros and cons to doing such a test and it is really important that before doing any genetic/cancer monitoring/predicting test, you speak to a clinician to determine if this is the right test for your, and how to manage the results.
Est. Result Turnaround Time : 4 hours
Related products
Well woman advanced
£357.94Polycystic ovary blood test – short POLYCYSTIC OVARY SYNDROME: SHORT
£213.90Glandular Fever Plus
£347.88Pre-pregnancy blood test
£414.00
